The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
Abstract
Aims: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. Methods and results: We generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca2+ cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca2+ cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis. Conclusions: The findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study by Schmitt and co-workers using transgenic mouse models expressing monomeric or pentameric PLN emphasizes the importance of the PLN pentamer-monomer equilibrium for SERCA function in the heart [79].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [79]
In the citing paper
“The AFA monomer is a slight gain-of-function mutant, and it presents several limitations as a functional model [79].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Greenberg, B., Butler, J., Felker, G. M., Ponikowski, P., Voors, A. A., Desai, A. S., Barnard, D., Bouchard, A., Jaski, B., Lyon, A. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00082-9 · Cited by 525 · cited 1×
“However, no improved clinical outcome was observed in a larger clinical trial that randomly assigned 250 patients to receive either AAV1/ SERCA2a or placebo, possibly due to insufficient expression of SERCA2a by the gene therapy vector.(52) All these strategies against heart failure via enhanced SR Ca uptake improved…”
Zsebo, K., Yaroshinsky, A., Rudy, J. J., Wagner, K., Greenberg, B., Jessup, M., & Hajjar, R. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.302421 · Cited by 315
Research works printed but not linked: 56
- Bers, 2000, Calcium fluxes involved in control of cardiac myocyte contraction, Circ Res, 87, 275, 10.1161/01.RES.87.4.275 · DOI · Paper page
- Mattiazzi, 2005, Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions, Cardiovasc Res, 68, 366, 10.1016/j.cardiores.2005.08.010 · DOI · Paper page
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Simmerman, 1996, A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure, J Biol Chem, 271, 5941, 10.1074/jbc.271.10.5941 · DOI · Paper page
- Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J Biol Chem, 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
- Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J Biol Chem, 275, 14985, 10.1074/jbc.275.20.14985 · DOI
- Autry, 1997, Functional co-expression of the canine cardiac Ca2+pump and phospholamban in spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation, J Biol Chem, 272, 15872, 10.1074/jbc.272.25.15872 · DOI · Paper page
- MacLennan, 1997, Sites of regulatory interaction between calcium ATPases and phospholamban, Basic ResCardiol, 92, 11, 10.1007/BF00794063 · doi:10.1007/bf00794063
- Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J Biol Chem, 283, 28996, 10.1074/jbc.M804782200 · doi:10.1074/jbc.m804782200
- Glaves, 2011, Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump, J Mol Biol, 405, 707, 10.1016/j.jmb.2010.11.014 · DOI
- Stokes, 2006, Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals, Biophys J, 90, 4213, 10.1529/biophysj.105.079640 · doi:10.1529/biophysj.105.079640
- Glaves, 2019, The phospholamban pentamer alters function of the sarcoplasmic Reticulum calcium pump SERCA, Biophys J, 116, 633, 10.1016/j.bpj.2019.01.013 · DOI
- Ceholski, 2012, Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A, J Biol Chem, 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
- Wittmann, 2015, Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers, J Mol Cell Cardiol, 80, 90, 10.1016/j.yjmcc.2014.12.020 · doi:10.1016/j.yjmcc.2014.12.020
- Koch, 2021, Molecular noise filtering in the β-adrenergic signaling network by phospholamban pentamers, Cell Rep, 36, 109448, 10.1016/j.celrep.2021.109448 · DOI
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Schmid, 2015, Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy, Nat Med, 21, 1298, 10.1038/nm.3972 · DOI · Paper page
- Haghighi, 2012, The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase, J Mol Cell Cardiol, 52, 773, 10.1016/j.yjmcc.2011.11.012 · DOI
- Schmitt, 2003, Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy, Circulation, 108, 1133, 10.1161/01.CIR.0000086469.85750.48 · doi:10.1161/01.cir.0000086469.85750.48
- Lorenz, 2008, A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy, Nat Med, 15, 75, 10.1038/nm.1893 · DOI · Paper page
- Blankenburg, 2014, β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations, Circ Res, 115, 227, 10.1161/CIRCRESAHA.115.303178 · DOI
- Schmitt, 2009, Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI
- Wu, 2007, Detecting protein–protein interactions by far western blotting, Nat Protoc, 2, 3278, 10.1038/nprot.2007.459 · DOI · Paper page
- Robia, 2007, Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ Res, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · doi:10.1161/circresaha.107.159947
- Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
- Verardi, 2011, Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method, Proc Natl Acad Sci, 108, 9101, 10.1073/pnas.1016535108 · DOI · Paper page
- Gustavsson, 2013, Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban, Proc Natl Acad Sci, 110, 17338, 10.1073/pnas.1303006110 · DOI · Paper page
- MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Schellenberger, 2002, Analysis of enzyme specificity by multiple substrate kinetics, Biochemistry, 32, 4344, 10.1021/bi00067a025 · doi:10.1021/bi00067a025
- Anderson, 2015, Multiple alternative substrate kinetics, Biochim Biophys Acta, 1854, 1729, 10.1016/j.bbapap.2015.05.016 · doi:10.1016/j.bbapap.2015.05.016
- Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
- Akin, 2013, The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum, J Biol Chem, 288, 30181, 10.1074/jbc.M113.501585 · DOI · Paper page
- Asahi, 2002, Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs), J Biol Chem, 277, 26725, 10.1074/jbc.C200269200 · DOI
- Chu, 1998, Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo, J Biol Chem, 273, 33674, 10.1074/jbc.273.50.33674 · doi:10.1074/jbc.273.50.33674
- Menzel, 2020, 14-3-3 Binding creates a memory of kinase action by stabilizing the modified state of phospholamban, Sci Signal, 13, eaaz1436, 10.1126/scisignal.aaz1436 · DOI · Paper page
- Li, 1990, Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation, Biochemistry, 29, 4535, 10.1021/bi00471a005 · DOI
- Jackson, 1996, Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca2+-pump stimulation, Biochem J, 316, 201, 10.1042/bj3160201 · DOI
- Fisher, 2021, Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA, Elife, 10, e65545, 10.7554/eLife.65545 · DOI
- Kiewitz, 2003, Ca2+-dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+-ATPase2a and phospholamban in the human heart, Biochem Biophys Res Commun, 306, 550, 10.1016/S0006-291X(03)00987-2 · DOI
- Eisner, 2013, Sarcoplasmic reticulum Ca-ATPase and heart failure 20 years later, Circ Res, 113, 958, 10.1161/CIRCRESAHA.113.302187 · DOI
- Kho, 2012, Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy, Nat Rev Cardiol, 9, 717, 10.1038/nrcardio.2012.145 · DOI · Paper page
- Kaye, 2007, Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals, J Am Coll Cardiol, 50, 253, 10.1016/j.jacc.2007.03.047 · DOI · Paper page
- Tsuji, 2009, Rescue of Ca2+overload-induced left ventricular dysfunction by targeted ablation of phospholamban, Am J Physiol Hear Circ Physiol, 296, 310, 10.1152/ajpheart.00975.2008 · doi:10.1152/ajpheart.00975.2008
- Dieterle, 2005, Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure, Cardiovasc Res, 67, 678, 10.1016/j.cardiores.2005.04.029 · DOI
- Del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 · DOI · Paper page
- Suckau, 2009, Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy, Circulation, 119, 1241, 10.1161/CIRCULATIONAHA.108.783852 · DOI · Paper page
- Beverborg, 2021, Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy, Nat Commun, 12, 1
- Nicolaou, 2009, Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury, Circ Res, 104, 1012, 10.1161/CIRCRESAHA.108.189811 · DOI
- Jessup, 2011, Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 304, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc Natl Acad Sci U S A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc Natl Acad Sci U S A, 108, 2735, 10.1073/pnas.1013987108 · DOI
- Mørk, 2007, Increased cardiomyocyte function and Ca2+transients in mice during early congestive heart failure, J Mol Cell Cardiol, 43, 177, 10.1016/j.yjmcc.2007.05.004 · DOI
- Kiss, 1995, Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels, Circ Res, 77, 759, 10.1161/01.RES.77.4.759 · DOI · Paper page
- Jiang, 1993, Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle, Circ Res, 72, 102, 10.1161/01.RES.72.1.102 · DOI
- Gergs, 2019, Alterations of protein expression of phospholamban, ZASP and plakoglobin in human atria in subgroups of seniors, Sci Rep, 9, 1, 10.1038/s41598-019-42141-w · DOI
- Reddy, 1999, Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry, 38, 3954, 10.1021/bi981795d · DOI · Paper page
Cited by
Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Metadata
- Authors
- Funk, F., Kronenbitter, A., Hackert, K., Oebbeke, M., Klebe, G., Barth, M., Koch, D., & Schmitt, J. P.
- Affiliations
- Institute of Pharmacology, University Hospital Düsseldorf, and Cardiovascular Research Institute Düsseldorf (CARID), Heinrich-Heine-University , Universitätsstraße 1, 40225 Düsseldorf , Germany
- Institute of Pharmaceutical Chemistry, Philipps-University Marburg , Marbacher Weg 6, 35032 Marburg , Germany
- Department of Cardiovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine-University , Moorenstr. 5, 40225 Düsseldorf , Germany
- Max Planck Institute for Neurobiology of Behavior—caesar, Cellular computations and learning group , Ludwig-Erhard-Allee 2, 53175 Bonn , Germany
- ORCID
- Schmitt, Joachim P
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-03-03
- Volume
- 119
- Issue
- 7
- Pages
- 1568-1582
- ISSN
- 0008-6363
- 1755-3245
- Cited by
- 28
- References
- 3
- Language
- en
- Funders
- Deutsche Forschungsgemeinschaft
- German Research Foundation (236177352- SFB 1116, TPA02 to J.P.S, SCHM1493/4-1 to J.P.S)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation. https://app.cochat.ai/papers/10.1093/cvr/cvad037
- The paper
- Funk, F., Kronenbitter, A., Hackert, K., Oebbeke, M., Klebe, G., Barth, M., Koch, D., & Schmitt, J. P. (2023). Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.